Recurrent venous thromboembolism after surgery-provoked versus unprovoked thromboembolism

Journal of Thrombosis and Haemostasis

Volumn 8, Issue 5, 2010, Pages 987-997

  White, R H ^a   Murin, S ^a   Wun, T ^a   Danielsen, B ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Health Information Solutions   (United States)

Author keywords

Epidemiology; Outcomes; Provoked; Recurrent; Surgery; Unprovoked; Venous thromboembolism

Indexed keywords

ACUTE DISEASE; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR RISK; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; EMERGENCY WARD; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RACE DIFFERENCE; RECURRENT DISEASE; RISK FACTOR; SEX DIFFERENCE; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM; ADOLESCENT; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; SURGERY;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; SURGICAL PROCEDURES, OPERATIVE; VENOUS THROMBOEMBOLISM;

EID: 77953754777     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2010.03798.x     Document Type: Article

References (44)

1. Hansson PO, Sörbo J, Eriksson H. Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Arch Intern Med 2000, 160:769-74.
2. Heit JA, Mohr DN, Silverstein MD, Petterson TM, O'Fallon WM, Melton LJ. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med 2000, 160:761-8.
3. Kearon C. Balancing risks and benefits of extended anticoagulant therapy for idiopathic venous thrombosis. J Thromb Haemost 2009, 7(Suppl 1):296-300.
4. Schulman S, Rhedin AS, Lindmarker P, Carlsson A, Larfars G, Nicol P, Loogna E, Svensson E, Ljungberg B, Walter H. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med 1995, 332:1661-5.
5. Pengo V, Lensing AW, Prins MH, Marchiori A, Davidson BL, Tiozzo F, Albanese P, Biasiolo A, Pegoraro C, Iliceto S, Prandoni P. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004, 350:2257-64.
6. Kahn SR, Kearon C, Julian JA, Mackinnon B, Kovacs MJ, Wells P, Crowther MA, Anderson DR, Van Nguyen P, Demers C, Solymoss S, Kassis J, Geerts W, Rodger M, Hambleton J, Ginsberg JS. Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis. J Thromb Haemost 2005, 3:718-23.
7. Zhu T, Martinez I, Emmerich J. Venous thromboembolism: risk factors for recurrence. Arterioscler Thromb Vasc Biol 2009, 29:298-310.
8. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008, 133:454S-545S.
9. White RH, Zhou H, Romano PS. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost 2003, 90:446-55.
10. Agnelli G, Prandoni P, Becattini C, Silingardi M, Taliani MR, Miccio M, Imberti D, Poggio R, Ageno W, Pogliani E, Porro F, Zonzin P. Extended oral anticoagulant therapy after a first episode of pulmonary embolism. Ann Intern Med 2003, 139:19-25.
11. Baglin T, Luddington R, Brown K, Baglin C. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet 2003, 362:523-6.
12. Christiansen SC, Cannegieter SC, Koster T, Vandenbroucke JP, Rosendaal FR. Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA 2005, 293:2352-61.
13. Prandoni P, Lensing AW, Cogo A, Cuppini S, Villalta S, Carta M, Cattelan AM, Polistena P, Bernardi E, Prins MH. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996, 125:1-7.
14. Prandoni P, Prins MH, Lensing AW, Ghirarduzzi A, Ageno W, Imberti D, Scannapieco G, Ambrosio GB, Pesavento R, Cuppini S, Quintavalla R, Agnelli G. Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial. Ann Intern Med 2009, 150:577-85.
15. Kearon C. Duration of therapy for acute venous thromboembolism. Clin Chest Med 2003, 24:63-72.
16. The Importance of Coding 2008, http://www.ahacentraloffice.org/ahacentraloffice/html/what_is_coding.html, [updated 2008; cited],
17. Schoenman JA, Sutton JP, Elixhauser A, Love D. Understanding and enhancing the value of hospital discharge data. Med Care Res Rev 2007, 64:449-68.
18. Grannis SJ, Overhage JM, McDonald CJ. Analysis of identifier performance using a deterministic linkage algorithm. Proc AMIA Symp 2002, 63:305-9.
19. Hser Y, Evans E. Cross-system data linkage for treatment outcome evaluation: lessons learned from the California Treatment Outcome Project. Eval Program Plann 2008, 2:125-35.
20. Computerised record linkage: compared with traditional patient follow-up methods in clinical trials and illustrated in a prospective epidemiological study. J Clin Epidemiol 1995, 48:1441-52.
21. White RH, Chew HK, Zhou H, Parikh-Patel A, Harris D, Harvey D, Wun T. Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults. Arch Intern Med 2005, 165:1782-7.
22. White RH, Zhou H, Murin S. Death due to recurrent thromboembolism among younger healthier individuals hospitalized for idiopathic pulmonary embolism. Thromb Haemost 2008, 99:683-90.
23. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care 1998, 36:8-27.
24. Southern DA, Quan H, Ghali WA. Comparison of the Elixhauser and Charlson/Deyo methods of comorbidity measurement in administrative data. Med Care 2004, 42:355-60.
25. Wilchesky M, Tamblyn RM, Huang A. Validation of diagnostic codes within medical services claims. J Clin Epidemiol 2004, 57:131-41.
26. Chaudhry S, Jin L, Meltzer D. Use of a self-report-generated Charlson Comorbidity Index for predicting mortality. Med Care 2005, 43:607-15.
27. Fieller E. Some problems in interval estimation. J Roy Stat Soc 1954, 16:175-85.
28. Kearon C, Ginsberg JS, Kovacs MJ, Anderson DR, Wells P, Julian JA, MacKinnon B, Weitz JI, Crowther MA, Dolan S, Turpie AG, Geerts W, Solymoss S, van NguyenP, Demers C, Kahn SR, Kassis J, Rodger M, Hambleton J, Gent M. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med 2003, 349:631-9.
29. Kyrle PA, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Eichinger S. The risk of recurrent venous thromboembolism in men and women. N Engl J Med 2004, 350:2558-63.
30. Spencer FA, Emery C, Joffe SW, Pacifico L, Lessard D, Reed G, Gore JM, Goldberg RJ. Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE study. J Thromb Thrombolysis 2009, 28:401-9.
31. Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, Prins MH, Raskob G, Segers AE, Cariou R, Leeuwenkamp O, Lensing AW. Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial. Ann Intern Med 2004, 140:867-73.
32. Houchens RL, Elixhauser A, Romano PS. How often are potential patient safety events present on admission? Jt Comm J Qual Patient Saf 2008, 34:154-63.
33. Naessens JM, Campbell CR, Berg B, Williams AR, Culbertson R. Impact of diagnosis-timing indicators on measures of safety, comorbidity, and case mix groupings from administrative data sources. Med Care 2007, 45:781-8.
34. White RH, Romano PS, Zhou H, Rodrigo J, Bargar W. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med 1998, 158:1525-31.
35. The predictive value of ICD-9-CM coding for deep-venous thrombosis (DVT) and pulmonary embolism (PE) [database on the Internet] 2009, http://www.blackwellpublishing.com/isth2009/abstract.asp?id=78948, [cited. Available from:
36. Heckbert SR, Kooperberg C, Safford MM, Psaty BM, Hsia J, McTiernan A, Gaziano JM, Frishman WH, Curb JD. Comparison of self-report, hospital discharge codes, and adjudication of cardiovascular events in the Women's Health Initiative. Am J Epidemiol 2004, 160:1152-8.
37. Cushman M, Tsai AW, White RH, Heckbert SR, Rosamond WD, Enright P, Folsom AR. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med 2004, 117:19-25.
38. Birman-Deych E, Waterman AD, Yan Y, Nilasena DS, Radford MJ, Gage BF. Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors. Med Care 2005, 43:480-5.
39. White RH, Sadeghi B, Tancredi DJ, Zrelak P, Cuny J, Sama P, Utter GH, Geppert JJ, Romano PS. How valid is the ICD-9-CM Based AHRQ Patient Safety Indicator for Postoperative Venous Thromboembolism? Med Care 2009, 47:1237-43.
40. Zhan C, Elixhauser A, Richards CL, Wang Y, Baine WB, Pineau M, Verzier N, Kliman R, Hunt D. Identification of hospital-acquired catheter-associated urinary tract infections from medicare claims: sensitivity and positive predictive value. Med Care 2009, 47:364-9.
41. Coffey RM, Milenkovic M, Andrews RM. The Case for the Present-on-Admission (POA) Indicator 2006, U.S. Agency for Healthcare Research and Quality
42. Glance LG, Dick AW, Osler TM, Mukamel DB. Does date stamping ICD-9-CM codes increase the value of clinical information in administrative data? Health Serv Res 2006, 41:231-51.
43. Glance LG, Osler TM, Mukamel DB, Dick AW. Impact of the present-on-admission indicator on hospital quality measurement: experience with the Agency for Healthcare Research and Quality (AHRQ) Inpatient Quality Indicators. Med Care 2008, 46:112-9.
44. Prandoni P, Noventa F, Ghirarduzzi A, Pengo V, Bernardi E, Pesavento R, Iotti M, Tormene D, Simioni P, Pagnan A. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica 2007, 92:199-205.